Peer Review History
| Original SubmissionFebruary 2, 2020 |
|---|
|
PONE-D-20-03043 Regulation of RpoS in production of prodigiosin and trade-off during prolonged stationary phase in Serratia marcescens 1912768R PLOS ONE Dear Dr Yi Cao, Thank you for submitting your manuscript to PLOS ONE. After careful consideration by two experts in the field, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the various points raised during the review process. We would appreciate receiving your revised manuscript by Apr 05 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Marie-Joelle Virolle, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements: 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.plosone.org/attachments/PLOSOne_formatting_sample_main_body.pdf and http://www.plosone.org/attachments/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ 3. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. 4. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data. 5. Please amend your list of authors on the manuscript to ensure that each author is linked to an affiliation. Authors’ affiliations should reflect the institution where the work was done (if authors moved subsequently, you can also list the new affiliation stating “current affiliation:….” as necessary). [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Review of PONE-D-20-03043 for PLoS One, “Regulation of RpoS in production of prodigiosin an trade-off during prolonged stationary phase in Serratia marcescens 1912768R. This study describes the enrichment of pigmentless mutants of S. marcescens during prolonged stationary phase. The basis of this loss of pigment was found to be mutation of the rpoS sigma factor gene, which is in opposition to what was previously shown by the Salmond group with another Serratia species. The defect in pigmentation was shown to be due to loss of transcription of the pig operon and not due to changes in growth. The rpoS mutant pigment defect was complemented by wild-type rpoS genes from a variety of Serratia species and Escherichia coli. Mutation in rpoS was demonstrated to have pleiotropic effects including increased susceptibility to a number of stresses. Additional data suggested that there is differential expression of OMPs and a selective growth advantage of the rpoS mutant in LB and minimal media. On the positive side, the figures are well put together. The data for the most part is good, particularly exciting are figure 1A/B and figure 4. There is a lot of room for improvement, particularly with respect to the major issues in the writing and some concerns with interpretation. Criticisms: 1. The major issue are the numerous writing issues (grammar and spelling) that weaken the manuscript. I have listed many below, but there are too many to list. 2. Line 21. Please change “which is” to “could be” – this is important because the results of this study suggest that loss of pigmentation will be a problem for industry, but this has not been reported as suggested by the current phrase. 3. Line 97. inconsistent with line 238. LB should be Lysogeny Broth, but Luria-Bertani is also accepted, but please be accepted. 4. Table 1. Inconsistent description of DH5a and S17-1 – please add the genotype for S17-1. 5. Table 1. Cut “widely used” for two plasmids, also replace knockout vector with “allelic replacement vector” 6. Line 148-151. Please be more specific about the mutant allele. For example, what base pairs are left. 7. Line 158-9. Replace “double-crossover recombination” with “second recombination”. Double cross-over is incorrect in this allelic replacement approach. 8. Methods line 183. Please describe what is meant by “treated chitin” and/or add a reference. 9. Line 185. What is meant by “skim sheep blood”? 10. Line 215-20. Please describe whether DNase was used in RNA preparation. 11. Line 234-5. Suggest changing the title to “Selective advantage for non-pigmented mutants during prolonged stationary phase”. Line 236. Change “cause” to “enrich for” 12. Figure 2. Should say “intergenic region” rather than “intergenic gene” 13. Line 289 – change “type to types”. Moreover, give some information on the amino acid identity of the RpoS protein. 14. Line 308 – consider adding the fold-change. It is hard to determine this looking at the linear scale of figure 4B. 15. Line 310. Consider adding “indicating that prodigiosin differences were not due to growth” 16. Line 320. It was very good using the same promoter for each rpoS gene. Please indicate that all genes were expressed from the rpoS promoter from 1912768R. 17. Line 339-340. “increased by several orders of magnitude” – this suggests that the Y-axis of Figure 5C was a log10 scale – please clarify whether it is log10 or linear. 18. Line 359-365. The loss of permeability using these assays is not well described. Are these well-established assays for permeability? I would suggest adding references for these. 19. Line 363-5. Is there any information on the predicted pore size of OmpC and OmpF? 20. Line 400-1. It seems that the promoters are more important than the genes for regulation of prodigiosin production. 21. Discussion – “data not shown” should not be included in the discussion section – this new data should be either moved to the results and shown or kept for a subsequent study. Line 410-414 and 442-445. 22. Figure 1C. The difference between R and WR is not clear in this image. A better picture would be helpful. 23. Figure 1A/B. Rename the Y-axis (left side) to “Surviving CFU/ml” or “Surviving Bacteria (CFU/ml)” 24. not clear whether some of the Y-axes are log scale or linear. Like figure Fig 5C, 7C, Grammatical issues and writing suggestions: 1. Line 24-5. Please use “Exhibited” rather than exhibiting, add “was” after (named 1912768WR). Cut “in the synthesis of the red pigmented secondary metabolite” as it is possibly confusing. 2. Line 29. Replace “disclosed that RpoS was pleiotropic” with “had pleiotropic effects” 3. Line 32. Replace colon with period. 4. Line 35. add “be” after “might” – also consider that the pig promoter rather than the pig cluster is important. 5. Line 41. cut “with RpoS involving in it” 6. Line Lines 50-55 – giant sentence – please fix. 7. Line 57. Change “secret” to “secrete” 8. Line 70. Cut “simple structured” – it is unnecessary. 9. Lines 74-76. Please fix this sentence. 10. Line 78. Cut “Except for these studies” 11. Line 86. Replace “these” with “this” 12. Line 88. Spelling of regulatory. 13. Line 139. Spelling of queried. 14. Line 146. Spelling of S. marcescens. 15. Line 165. Change “were” to “was” 16. Line 181-2. Remove “detection”, and add “of Slater, et al.” after “method” 17. Lines 193-4. Please fix the sentence. 18. Line 212. Change “was” to “were” 19. Please change “at almost the 16th day” to “sound day 16”. 20. Lines 283-287. Many issues. Add period after type I. Change “besides” to “since or because”, replace “and” on line 284 with a coma. “regulating to regulate”.. change “be the reason causing the loss” to “underly / lead to the observed”. Line 286 add “were” after “that”. Add “for strains WR and W respectively” after “3”. 21. Line 323. Change “impacts” to “effects” 22. Line 342. Change “resulting” with “which is consistent with” 23. Line 344-5. Change “resistant” to “resistance” and cut “ability” 24. Line 366 and 371. Spelling of “membrane permeability” and “medium” 25. Line 373. Space after “colony.” 26. Line 388 and 392. Spelling of “production” and “species” 27. Line 413-420 – add “be” after might on 413 and after may on line 414. Line 415 change rpoS to RpoS, line 418 change “researches are” to “research is”. Line 420, spelling of “strains”. 28. Line 443. Replace “an” with “the” 29. Line 467-8. Cut “in our study” 30. Figure 4B. Y-axis – should be “pigA” rather than PigA. Reviewer #2: Manuscript Number: PONE-D-20-03043 Manuscript Title: Regulation of RpoS in production of prodigiosin and trade-off during prolonged stationary phase in Serratia marcescens 1912768R This manuscript addresses the problem of loss of prodigiosin production in stationary-phase cultures of Serratia marcescens. Prodigiosin-defective mutants of S. marcescens strain 1912768R were isolated from long-term stationary-phase cultures. Strain 1912768WR was partially deficient in prodigiosin production, while strain 1912768W was entirely deficient in prodigiosin production. The genomes of these two mutants (1912768WR and 1912768W) were sequenced and compared to parent strain 1912768R. Genome analysis revealed that 1912768WR and 1912768W carried mutations in the rpoS gene. An rpoS deletion mutant of parent strain 1912768R was constructed (strain �rpoS) and used in subsequent experiments. Complementation studies were also performed using a plasmid-borne copy of “wild-type” rpoS from parent strain 1912768R. The deletion mutant was defective in prodigiosin production and this phenotype was restored by the complementation plasmid. The authors also show that transcription of the pigment operon (pigA transcript) was downregulated in the deletion mutant. In addition, the authors demonstrate that many other phenotypes were affected by the rpoS deletion including biofilm formation, motility, cellular arrangement, the production of extracellular enzymes, the production of siderophores, and the transcription of genes involved in flagella biosynthesis. The authors also show that the rpoS deletion caused a decrease in resistance to several forms of stress and a general increase in membrane permeability, including changes in OmpC and OmpF levels, and taken together, suggesting a role in the “SPANC balance” of S. marcescens. Lastly, the rpoS deletion strain outcompeted the parent strain in growth studies in both rich and minimal media. The authors conclude that the loss of RpoS is the primary reason for the loss of prodigiosin production in strains 1912768WR and 1912768W. The data regarding rpoS mutations and their effects on stress resistance, growth, and membrane permeability are not very surprising, as RpoS is a well-known stress-response regulator in the Enterobacteriaceae. The role of RpoS in the stationary-phase-inducible, general-stress-responses of Escherichia coli and Salmonella enterica serovar Typhimurium have been well documented in recent decades, and the authors are missing some important references in this research field. However, the data does provide evidence that prodigiosin is RpoS-regulated in Serratia marcescens. The other data presented in this manuscript provide evidence of an extensive RpoS-regulon in S. marcescens, but how this is relevant to prodigiosin production is less clear. Although the authors show that RpoS-regulated functions are involved in various types of stress resistance and in growth rate, evidence that prodigiosin production is somehow directly connected to the SPANC balance in Serratia marcescens is again unclear. Is a potential connection between prodigiosin and other RpoS-regulated functions being inferred? Does less prodigiosin biosynthesis result in less stress resistance and greater nutritional competence? Perhaps the manuscript should focus on the RpoS regulon of Serratia marcescens instead of just focusing on prodigiosin production. In other words, a different manuscript title might solve some of these issues. Overall, it seems that the study of prodigiosin-deficient mutants led to the discovery of an RpoS regulon in this organism. Furthermore, the authors begin to discuss possible differences in the RpoS regulation of pig loci (prodigiosin biosynthesis operons) in different S. marcescens strains. This is an interesting point of discussion, but is not explained enough in the manuscript. An additional figure illustrating the potential differences in pig regulation could be helpful. In fact, any potential differences between the RpoS-regulated functions of this organism (1912768R) and those of other S. marcescens strains, or closely related species, should be emphasized more in the body of the manuscript. The experimental strategies and methods appear to be scientifically sound, and there was sufficient statistical analysis of the data. But again, the authors’ findings with S. marcescens were somewhat predictable based on what is already known about the RpoS regulons of closely related species. There are extensive English language issues throughout the manuscript. One result of these language problems is that the actual experimental data is not always described sufficiently in a clear manner. Some important experimental results are only described in a couple of sentences, and their impact is lost in the overall body of the manuscript. There are also several typographic errors throughout the manuscript, a few examples of which are listed below: Line 86: “theses” should be “these” Line 366: “menbrane” should read “membrane” Line 388: “produciton” should read “production” Line 392: “spicies” should be “species” ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
RpoS is a pleiotropic regulator of motility, biofilm formation, exoenzymes, siderophore and prodigiosin production, and trade-off during prolonged stationary phase in Serratia marcescens PONE-D-20-03043R1 Dear Dr. Cao, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Marie-Joelle Virolle, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors adequately addressed my comments and concerns and the manuscript is greatly improved. I think that it is a nice addition to the field. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Robert M. Q. Shanks |
| Formally Accepted |
|
PONE-D-20-03043R1 RpoS is a pleiotropic regulator of motility, biofilm formation, exoenzymes, siderophore and prodigiosin production, and trade-off during prolonged stationary phase in Serratia marcescens Dear Dr. Cao: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Marie-Joelle Virolle Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .